Impaired hypoxic cerebral vasodilation in younger adults with metabolic syndrome

Diabetes and Vascular Disease Research

Volumn 10, Issue 2, 2013, Pages 135-142

  Harrell, John W ^a   Morgan, Barbara J ^b   Schrage, William G ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin   (United States)

Author keywords

Cerebral blood flow; risk factors; transcranial Doppler

Indexed keywords

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HUMAN; HYPERCAPNIA; HYPOXIA; IMPAIRED CEREBRAL VASODILATION; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; MIDDLE CEREBRAL ARTERY; VASODILATATION;

ADULT; ANOXIA; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; HYPERCAPNIA; MALE; METABOLIC SYNDROME X; MIDDLE CEREBRAL ARTERY; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASODILATION;

EID: 84867098381     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164112448875     Document Type: Article

References (42)

1. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005 ; 112: 2735-2752
2. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007 ; 92: 399-404
3. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010 ; 56: 1113-1132
4. Wild SH, Byrne CD, Tzoulaki I, et al. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study. Atherosclerosis. 2009 ; 203: 604-609
5. Silvestrini M, Vernieri F, Pasqualetti P, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA. 2000 ; 283: 2122-2127
6. Marshall RS, Rundek T, Sproule DM, et al. Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke. 2003 ; 34: 945-949
7. Zimmermann C, Wimmer M, Haberl RL. L-arginine-mediated vasoreactivity in patients with a risk of stroke. Cerebrovasc Dis. 2004 ; 17: 128-133
8. Deutsch C, Portik-Dobos V, Smith AD, et al. Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke. Microvasc Res. 2009 ; 78: 100-106
9. Giannopoulos S, Boden-Albala B, Choi JH, et al. Metabolic syndrome and cerebral vasomotor reactivity. Eur J Neurol. 2010 ; 17: 1457-1462
10. Przybylowski T, Bangash MF, Reichmuth K, et al. Mechanisms of the cerebrovascular response to apnoea in humans. J Physiol. 2003 ; 548: 323-332
11. McSwain SD, Hamel DS, Smith PB, et al. End-tidal and arterial carbon dioxide measurements correlate across all levels of physiologic dead space. Respir Care. 2010 ; 55: 288-293
12. Buckwalter JB, Naik JS, Valic Z, et al. Exercise attenuates alpha-adrenergic-receptor responsiveness in skeletal muscle vasculature. J Appl Physiol. 2001 ; 90: 172-178
13. Reichmuth KJ, Dopp JM, Barczi SR, et al. Impaired vascular regulation in patients with obstructive sleep apnea: effects of continuous positive airway pressure treatment. Am J Respir Crit Care Med. 2009 ; 180: 1143-1150
14. Shpirer I, Elizur A, Shorer R, et al. Hypoxemia correlates with attentional dysfunction in patients with obstructive sleep apnea. Sleep Breath. 2011 ;:
15. Lurie A. Endothelial dysfunction in adults with obstructive sleep apnea. Adv Cardiol. 2011 ; 46: 139-170
16. Chen XY, Thomas GN, Chen YK, et al. Atherosclerotic vascular disease rather than metabolic syndrome predicts ischemic stroke in diabetic patients. Cerebrovasc Dis. 2010 ; 30: 374-379
17. Battisti-Charbonney A, Fisher J, Duffin J. The cerebrovascular response to carbon dioxide in humans. J Physiol. 2011 ; 589: 3039-3048
18. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998 ; 78: 53-97
19. Van Mil AH, Spilt A, Van Buchem MA, et al. Nitric oxide mediates hypoxia-induced cerebral vasodilation in humans. J Appl Physiol. 2002 ; 92: 962-966
20. Reid JM, Davies AG, Ashcroft FM, et al. Effect of L-NMMA, cromakalim, and glibenclamide on cerebral blood flow in hypercapnia and hypoxia. Am J Physiol. 1995 ; 269: H916 - H922
21. Ide K, Worthley M, Anderson T, et al. Effects of the nitric oxide synthase inhibitor L-NMMA on cerebrovascular and cardiovascular responses to hypoxia and hypercapnia in humans. J Physiol. 2007 ; 584: 321-332
22. Fredricks KT, Liu Y, Rusch NJ, et al. Role of endothelium and arterial K+ channels in mediating hypoxic dilation of middle cerebral arteries. Am J Physiol. 1994 ; 267: H580 - H586
23. Erdos B, Miller AW, Busija DW. Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am J Physiol Heart Circ Physiol. 2002 ; 282: H2060 - H2065
24. Fan JL, Burgess KR, Thomas KN, et al. Influence of indomethacin on the ventilatory and cerebrovascular responsiveness to hypoxia. Eur J Appl Physiol. 2011 ; 111: 601-610
25. Phillips SA, Sylvester FA, Frisbee JC. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2005 ; 288: R522 - R530
26. Erdos B, Snipes JA, Miller AW, et al. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes. 2004 ; 53: 1352-1359
27. Erdos B, Simandle SA, Snipes JA, et al. Potassium channel dysfunction in cerebral arteries of insulin-resistant rats is mediated by reactive oxygen species. Stroke. 2004 ; 35: 964-969
28. Fan JL, Burgess KR, Thomas KN, et al. Influence of indomethacin on ventilatory and cerebrovascular responsiveness to CO2 and breathing stability: the influence of PCO2 gradients. Am J Physiol Regul Integr Comp Physiol. 2010 ; 298: R1648 - R1658
29. Xie A, Skatrud JB, Morgan B, et al. Influence of cerebrovascular function on the hypercapnic ventilatory response in healthy humans. J Physiol. 2006 ; 577: 319-329
30. Schmetterer L, Findl O, Strenn K, et al. Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans. Am J Physiol. 1997 ; 273: R2005 - R2012
31. White RP, Deane C, Vallance P, et al. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke. 1998 ; 29: 467-472
32. Schreiber SJ, Gottschalk S, Weih M, et al. Assessment of blood flow velocity and diameter of the middle cerebral artery during the acetazolamide provocation test by use of transcranial Doppler sonography and MR imaging. AJNR Am J Neuroradiol. 2000 ; 21: 1207-1211
33. Serrador JM, Picot PA, Rutt BK, et al. MRI measures of middle cerebral artery diameter in conscious humans during simulated orthostasis. Stroke. 2000 ; 31: 1672-1678
34. Kirkham FJ, Padayachee TS, Parsons S, et al. Transcranial measurement of blood velocities in the basal cerebral arteries using pulsed Doppler ultrasound: velocity as an index of flow. Ultrasound Med Biol. 1986 ; 12: 15-21
35. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008 ; 7: 476-484
36. Romer LM, Haverkamp HC, Lovering AT, et al. Effect of exercise-induced arterial hypoxemia on quadriceps muscle fatigue in healthy humans. Am J Physiol Regul Integr Comp Physiol. 2006 ; 290: R365 - R375
37. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev. 2005 ; 9: 211-224
38. Ringelstein EB, Van Eyck S, Mertens I. Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide. J Cereb Blood Flow Metab. 1992 ; 12: 162-168
39. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010 ; 182: 269-277
40. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004 ; 292: 2237-2242
41. Vuorinen M, Solomon A, Rovio S, et al. Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study. Dement Geriatr Cogn Disord. 2011 ; 31: 119-125
42. Kleindorfer DO, Khoury J, Moomaw CJ, et al. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010 ; 41: 1326-1331